Replies to post #254369 on Elite Pharmaceuticals Inc (ELTP)

[mrwrn2010]

Let's see some.

Highly doubt any of them have anywhere near Elite's potential market reach.

[NASDAQ2020]

Reformulated SequestOx™ will be the first IR ADF opiod to receive ORAL, Nasal and IV ADF labeling
Inspirion's RoxyBond lost big by not getting oral AD labeling
SequestOx will make their product obsolete by years end.
Reformulated SequestOx™ with lowered fed Tmax is now the SAFEST Immediate Release opiod in the world, and the only one using a Pharmalogical Approach to abuse deterrence.
To date there have been no adverse events with Elites SequestOx™,
This is what Congress, President, FDA and the Public are looking for.
Perfect storm for Elite, right place-right time

SequestOx™ Elite's market disruptive ADF labeled Immediate Release opiod
can not be abused by:

NASAL:
Insuffalation/snorting all particle sizes

IV:
injecting/IV/poor syringe ability

Smoking:

ORAL:
chewing
crushing/mechanical manipulation
grating
milling
sucking
splitting
breaking
grinding
use with alcohol
sandpapering
blended
melting
microwave
baking
freezing
extracting
centrifuging
bead separation
difficult to defeat with common solvents

[Couch]

So what did Elite's HAL and Efficacy data show???

[NASDAQ2020]

Elite's Multi-Billion Dollar Platform:
Elite's Current Marketed Products and Pipeline is growing rapidly ! Fully developed its worth Billion$
Start watching for the undisclosed drug filings.
$$$$$$$$$$$$
Elite working on 7 AD opiods concurrently
Elite just one launch from being Cash Low Positive

$Generic Products$$

Commercial Product
Branded Product Equivalent
Therapeutic Category u

1. Hydromorphone Hydrochloride
8 mg Tablets
Dilaudid®
Pain

2. Naltrexone Hydrochloride
50 mg Tablets
Revia®
Opioid Antagonist

3. Phentermine HCl
37.5 mg Tablets
Adipex-P®
Bariatric

4. Phentermine HCI
15 mg and 30 mg Capsules
Adipex-P®
Bariatric

5. Phendimetrazine Tartrate
35 mg Tablets, USP
Bontril®
Bariatric

6. Isradipine
2.5 mg and 5 mg Capsules
N/A
Cardiovascular

7. Hydroxyzine HCI
10 mg, 25 mg, 50 mg Tablets
Atarax®, Vistaril®
Antihistamine

8. Dantrolene Sodium
25 mg, 50 mg and 100 mg Capsules *
Dantrium®
Skeletal Muscle Relaxant

9. Loxapine
5 mg, 10 mg, 25 mg, 50 mg Capsules *
N/A
Antipsychotic

10. Additional Approved ANDA's *
Undisclosed
Undisclosed
* pending manufacturing site transfer


$BRANDED PRODUCTS$$
Commercial Product
Therapeutic Category
Partner

11. Lodrane D®
OTC Allergy
Valeant Pharmaceuticals International, Inc.


$CONTRACT MANUFACTURING$$
Commercial Product
Branded Product Equivalent
Therapeutic Category
Partner

12. Methadone Hydrochloride
10 mg Tablets
Dolophine®
Pain
Ascend Laboratories, LLC


$GENERIC PIPELINE$$

Programs Under Development
Branded Product Equivalent
Therapeutic Category
Development Stage

13. ELI-300 Opioid
Undisclosed
Pain
Early Development

14. ELI-301 Opioid
Undisclosed
Pain
Early Development

15. Oxycodone HCl and Acetaminophen, USP 325 mg
5 mg, 7.5 mg, 10 mg Tablets
Percocet
Pain
Pending FDA Approval

16. Hydrocodone bitartrate and Acetaminophine tablets, 2.5mg/325mg, 5mg/325mg, 7.5mg/325mg and 10mg/325mg tablets
Norco
Pain
Pending FDA Approval


17. Undisclosed Generic
Undisclosed
Undisclosed
Pending FDA Approval

18. Elite/SunGen Generic #1
Undisclosed
CNS Stimulant
In Development

19. Elite/SunGen Generic #2
Undisclosed
CNS Stimulant
In Development

20. Elite/SunGen Generic #3
Undisclosed
Beta-Blocker
In Development

21. Elite/SunGen Generic #4
Undisclosed
Beta-Blocker
In Development

22. Generic Troxyca
Pain

23. Generic Embeda
Pain

24. Generic OxyContin

25. Generic Opana Oxymorphone
Pain


$BRANDED PIPELINE$$

Development Stage
Partner

26. SequestOx™ (ELI-200) Opioid
Pain
NDA Submitted
PDUFA date: July 14, 2016
Epic Pharma LLC

27. ELI-201 ER Opioid
Troxyca equivalent
Pain
Pivotal Bio-equivalence

28. ELI-202 Opioid
Pain
Pivotal Bio-equivalence

29. ELI-216 Opioid ER 24hr (once/day)
Pain
Process Development

30. ELI-400 Opioid
Pain
Process Development

31., ELI-500 Opioid
Pain
Process Development

32. ELI-501 Opioid
Pain
Early Development

33. ELI-600 Opioid
Pain
Process development ELTP
ELTP

[NASDAQ2020]

Elite will have a 100% HammerLock on these markets:

Any BP would love to have this in their pipeline.
Elite modular tech makes it possible to make any IR, ER, 4, 6, 8, 12 24 hr ADF opiod.

ELTP

1.) Oral, IV, and Nasal abuse deterrent labeled Immediate Release opiod
----------- SequestOx™ ----------
2.) ER ADF labeled Oxycodone (ELI-201)
3.) generic Embeda®
4.) generic ADF reformulated OxyContin®
5.) generic Troxyca®
6.) 24 hour (once per day) ADF oxycodone ELI-216

Hammer Time !!!

[Jimmy Joe]

There are also non-profitable companies on NASDAQ that are valued
in dollars. Your point?

Elite has multiple opioid ADF drugs in their pipeline. Extended release drugs yet to be counted. They get this IR SequestOx and the others in their pipeline are likely to be much easier.

What is the prescription opioid abuse like in the US? Bad and getting worse.
Philly DA race..... one of the hot topics is the pill mills that are rampant. Big Pharma is another topic of the Philly DA race.
Go after Big Pharma. So if Elite has a solution... whose formulation is likely to be dominant? OxyContin tamper resistant? or SequestOx ADF?